|1.||Boumendjel, Ahcene: 2 articles (07/2012 - 01/2009)|
|2.||Boutonnat, Jean: 2 articles (07/2012 - 01/2009)|
|3.||Bouchet, Audrey: 1 article (07/2012)|
|4.||Serduc, Raphael: 1 article (07/2012)|
|5.||Laissue, Jean A: 1 article (07/2012)|
|6.||Siegbahn, Erik Albert: 1 article (07/2012)|
|7.||Bräuer, Elke: 1 article (07/2012)|
|8.||Khalil, Enam: 1 article (07/2012)|
|9.||Derouazi, Madiha: 1 article (01/2009)|
|10.||Champelovier, Pierre: 1 article (01/2009)|
|1.||Brain Neoplasms (Brain Tumor)
|2.||Glioblastoma (Glioblastoma Multiforme)
01/01/2009 - "In the four human and the murine glioblastoma cell lines tested, 10 muM JAI-51 inhibited proliferation and blocked cells in the M phase of the cell cycle, via its activity as a microtubule depolymerising agent. "
01/01/2009 - "The in-vitro activities of JAI-51 on cell proliferation were assessed by various experimental approaches in four human and a murine glioblastoma cell lines. "
01/01/2009 - "These in vitro studies were reinforced by our in vivo investigations of C57BL/6 mice bearing GL26 glioblastoma xenografts, in which JAI-51 induced a delay in tumour onset and a tumour growth inhibition, following intraperitoneal administration of 96 mg/kg once a week. "
07/01/2012 - "As MRT alone is predominantly palliative for animal tumors, the effects of the combination of MRT and a newly synthesized chemotherapeutic agent JAI-51 on 9L gliosarcomas have been evaluated. "
07/01/2012 - "The combination of MRT and JAI-51 increases the survival of 9LGS-bearing rats by inducing endoreduplication of DNA and tumor cell death; further, it slowed the onset of tumor growth resumption two weeks after treatment."
|2.||DNA (Deoxyribonucleic Acid)
|2.||Heterologous Transplantation (Xenotransplantation)